G GILD

Gilead Sciences Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Gilead Sciences, Inc. is a leading biopharmaceutical company based in Foster City, California, renowned for its pioneering advancements in antiviral therapeutics, especially for HIV and hepatitis. The company's innovative treatments, such as Harvoni and Sovaldi, have fundamentally transformed the ma...

$130.69

+0.15% (+$0.19)

Volume 5.57M

52W High $157.29

52W Low $103.05

Market Cap $167.80B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

May 7, 2026 Beat

Actual: $2.03 vs. Consensus: $1.89

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q1 2026 May 7, 2026

1-Day: -2.04%

5-Day: +0.66%

Q1 2026 Apr 23, 2026

1-Day: -2.42%

5-Day: -3.28%

Q4 2025 Feb 10, 2026

1-Day: +5.82%

Q3 2025 Oct 30, 2025

1-Day: +1.14%

5-Day: +3.85%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q1'26	$6.96B	+4.4%	79.2%	37.2%	$2.02B
Q4'25	$7.92B	+4.7%	79.5%	37.7%	$2.18B
Q3'25	$7.77B	+3.0%	79.8%	42.8%	$3.05B
Q2'25	$7.08B	+1.8%	78.8%	34.9%	$1.96B
Q1'25	$6.67B	-0.3%	76.9%	33.6%	$1.32B
Q4'24	$7.57B	+6.4%	79.1%	32.4%	$1.78B
Q3'24	$7.55B	+7.0%	79.1%	11.8%	$1.25B
Q2'24	$6.95B	+5.4%	77.8%	38.0%	$1.61B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	May 7, 2026	$1.89	$1.79	$2.03	+7.41%	Beat
Q1 2026	Apr 23, 2026	$1.89	$1.96	$2.03	+7.41%	Beat
Q4 2025	Feb 10, 2026	$1.85	$1.90	$1.86	+0.54%	Missed
Q3 2025	Oct 30, 2025	$2.15	$2.32	$2.47	+14.88%	Beat
Q2 2025	Aug 7, 2025	$1.96	$2.15	$2.01	+2.55%	Missed
Q1 2025	May 8, 2025	$1.77	$1.94	$1.81	+2.11%	Missed
Q1 2025	Apr 24, 2025	$1.77	$1.94	$1.81	+2.11%	Missed
Q4 2024	Feb 11, 2025	$1.70	$1.88	$1.90	+11.73%	Met
Q4 2024	Feb 4, 2025	$1.70	$1.85	$1.90	+11.73%	Beat
Q3 2024	Nov 6, 2024	$1.55	$1.66	$2.02	+30.32%	Beat
Q2 2024	Aug 8, 2024	$1.60	$1.69	$2.01	+25.62%	Beat
Q1 2024	Apr 25, 2024	-$1.49	-$1.49	-$1.32	+11.41%	Beat